UMass Medical School professor co-recipient of Nobel Prize

VICTOR AMBROS

VICTOR AMBROS

Craig Mello, left, 2006 recipient of the Nobel Prize for Physiology or Medicine, stands with Victor Ambros, 2024 Nobel Prize winner in physiology or medicine, during a news conference at the University of Massachusetts Medical School on Monday in Worcester.

Craig Mello, left, 2006 recipient of the Nobel Prize for Physiology or Medicine, stands with Victor Ambros, 2024 Nobel Prize winner in physiology or medicine, during a news conference at the University of Massachusetts Medical School on Monday in Worcester. AP

By EMMA ROTH-WELLS

Valley News

Published: 10-07-2024 8:17 PM

HARTLAND, Vt. — Born in Hanover, New Hampshire, and raised on a family farm in Hartland, Vermont, University of Massachusetts Medical School professor Victor Ambros said his early life prepared him for life as a scientist.

“Farmers are do-it-yourself-ers,” said Ambros, now 70, in a phone interview on Monday. “I learned from my father and neighbors that if you want something to work in a certain way, you can build something to make that happen.”

Ambros’ approach was rewarded on Monday when he and his colleague Gary Ruvkun won the Nobel Prize in physiology or medicine for their discovery of microRNA, tiny bits of genetic material that offer a way for scientists to control what’s happening in our cells and could lead to new ways of detecting and treating diseases including cancer.

The Nobel Prize-winning discovery was “a fundamental principle governing how gene activity is regulated,” according to a news release announcing Ambros and Ruvkun as the prize winners.

Ruvkun is a professor of genetics at Harvard Medical School and a principle investigator at Massachusetts General Hospital in Boston.

“I’m surprised and delighted, especially to be recognized with my friend,” Ambros said.

Back in the late 1980s, while conducting research in separate labs at Harvard, Ambros and Rukven came across microRNAs in the genes of 1-millimeter-long roundworms called nematodes, which are often used as a model organism in research.

They set out to identify the mutated genes responsible for cell development in these worms and to determine their role. The mechanism they ultimately identified — the regulation of genes by microRNA — has allowed organisms to evolve for hundreds of millions of years.

Article continues after...

Yesterday's Most Read Articles

Northampton fire crews contain brush fire in Fitzgerald Lake Conservation Area, work to put out blaze that swept through 52 acres
Easthampton woman pleads guilty to fatal stabbing of ex-boyfriend, sentenced to 16-19 years for manslaughter
Around the Hamptons: Easthampton family seeks help after car crashes into home
Chance Encounters with Bob Flaherty: A heartful of sound: Band Day with the ‘power and class of New England’
Northampton gateway properties near I-91, primed for development, bought as group
UMass basketball: New-look Minutemen eye opener with UNH to kick off final Atlantic 10 season

RNA is best known for carrying instructions for how to make proteins from DNA in the nucleus of the cell to tiny cellular factories that actually build the proteins. MicroRNA does not make proteins, but helps to control what cells are doing, including switching on and off critical genes that make proteins.

When it comes to diseases such as cancer, Ambros said microRNA “offer opportunities for intervention” that can be used in therapies such as inducing tumor suppression, according to the National Institutes of Health.

“Their groundbreaking discovery revealed a completely new principle of gene regulation that turned out to be essential for multicellular organisms, including humans,” according to the Monday news release from The Nobel Assembly at Karolinska Institutet.

Ambros’ current research is along similar lines.

“We continue to focus on mechanisms whereby genes regulate each other in ways that are important for animal development,” said Ambros. He said his research also focuses on “questions related to developmental clocks and timing.”

This week’s prize comes after the two men were honored for the same discovery with the $3 million Breakthrough Prize for life sciences in 2014.

The Breakthrough Prizes were founded by Google founder Sergey Brin, Meta founders Priscilla Chan and Mark Zuckerberg, Russian entrepreneur Yuri Milner and his wife Julia Milner, and Anne Wojcicki, CEO of 23&me. The prize is sponsored by the personal funds of the founders and Chinese entrepreneurs Ma Huateng and Jack Ma, according to its website.

Ambros said he doesn’t remember a time when he didn’t want to be a scientist.

“It’s something I latched onto very early,” he said.

Decades before winning scientific awards, Ambros began his scholarship with grade school in Hartland, where he said he “benefited from key teachers who really encouraged inquiry and problem solving,” particularly Wallace Vaine.

Growing up he was “not a genius and not particularly talented in any special way,” he told the Valley News in 2014.

He graduated from Woodstock (Vt.) High School in 1971 and earned his bachelor’s degree and doctorate from the Massachusetts Institute of Technology. He became principal investigator at Harvard in 1985, then a tenured professor at Dartmouth College’s Geisel School of Medicine from 1992-2007.

He and his wife, Rosalind Lee, still own a house in Hanover where they often spend time.

Lee is the first author of the paper that reported the discovery that garnered the Nobel.

“She’s been a collaborator, a lab manager and at the same time she manages the family,” said Ambros. “She is absolutely vital to everything I am.”

The couple have three sons all of whom spent the later part of their childhood in Hanover after the family moved from Waltham in 1992 for Ambros’ position at Dartmouth.

Ambros and Ruvkun will travel to Stockholm in December to accept the Nobel prize, which includes $1 million from a fund left by the prize’s creator, Swedish inventor Alfred Nobel.

Emma Roth-Wells can be reached at erothwells@vnews.com or 603-727-3242. Material from the Associated Press was used in this report.